Institutional Mismatch: The Fragility of Biotech Governance
FDA leadership changes cause delays and confusion for new biotech drug approvals. Scientists and investors are affected by the lack of clear rules.
#FDADelays, #BiotechNews, #DrugApproval, #USPolitics, #HealthcareUpdate
https://newsletter.tf/fda-leadership-loss-biotech-drug-approvals-2026/


